FIGURE 2.
Rolling four-week new prescriptions
Source: SDI/Verispan VONA, NRx: sleep aid market, benzodiazepine class, and antidepressant market
Rolling four-week new prescriptions
Source: SDI/Verispan VONA, NRx: sleep aid market, benzodiazepine class, and antidepressant market